Letter by Nezami et al Regarding Article, “Platelet Reactivity and Cardiovascular Outcomes After Percutaneous Coronary Intervention: A Time-Dependent Analysis of the Gauging Responsiveness With a VerifyNow P2Y12 Assay: Impact on Thrombosis and Safety (GRAVITAS) Trial” | Zendy

Nariman Nezami | Zendy; Ourmaan Nezami Nargabad | Zendy; Sona Ghorashi | Zendy

Open Access

Letter by Nezami et al Regarding Article, “Platelet Reactivity and Cardiovascular Outcomes After Percutaneous Coronary Intervention: A Time-Dependent Analysis of the Gauging Responsiveness With a VerifyNow P2Y12 Assay: Impact on Thrombosis and Safety (GRAVITAS) Trial”

Author(s) -

Nariman Nezami,

Ourmaan Nezami Nargabad,

Sona Ghorashi

Publication year - 2012

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.111.068346

Subject(s) - medicine , percutaneous coronary intervention , clopidogrel , p2y12 , conventional pci , acute coronary syndrome , cardiology , coronary artery disease , aspirin , myocardial infarction

To the Editor:We read with great interest the article by Price et al1 in a recent issue of Circulation . The authors concluded that achievement of on-treatment platelet reactivity (OTR) <208 P2Y12 reaction units at 12 to 24 hours after percutaneous coronary intervention (PCI) or during follow-up was associated with a lower risk for cardiovascular events. Considering the potential clinical implications of this attractive study, addressing some methodological issues would be appreciated.The GRAVITAS trial1 enrolled patients after PCI with 1 or more drug-eluting stents for the treatment of stable coronary artery disease or non–ST-elevation acute …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research